Wells Fargo Starts Lion Biotechnologies (LBIO) at Outperform
Tweet
Share
E-mailGet Alerts LBIO Hot Sheet
Price: $6.95 --0%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
Wells Fargo initiates coverage on Lion Biotechnologies (NASDAQ: LBIO) with a Outperform rating.
For an analyst ratings summary and ratings history on Lion Biotechnologies click here. For more ratings news on Lion Biotechnologies click here.
Shares of Lion Biotechnologies closed at $7.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
- Alliance Global Partners Starts Momentus (MNTS) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
